Vigiis 101-LAB

Products

Information

Vigiis® 101-LAB (Lactobacillus paracasei subsp. paracasei NTU 101) was discovered by National Taiwan University after screening hundreds of bacterial strains. Supported by 40 SCI publications, this clinically proven probiotic from SunWay Biotech boasts an impressive 95% survival rate against gastric acid and bile salts. It serves as a revolutionary solution, specifically crafted for relieving symptoms of atopic dermatitis. Vigiis® 101-LAB is designed to effectively promote the generation of regulatory T cells (Treg), as well as Th1/Th2 balance, which play a crucial role in regulating immune responses. This helps reduce excessive immune reactions and inflammation, thereby alleviating skin discomfort. By balancing the gut flora, Vigiis® 101-LAB not only enhances overall immunity for atopic dermatitis but also improves constipation and maintains the stomach’s mucosal lining. This helps you manage the challenges of atopic dermatitis with ease.

SunWay Biotech6824“SunWay Biotech Co., LTD.” was founded in 2007. The core values of the company focus on professional R&D and technical material manufacturing and processing. By collaborating with Professor Tzu-Ming Pan from Department of Biochemical Science and Technology, College of Life Science, National Taiwan University, our company is devoted to the research, design and manufacturing of Monascus purpureus NTU 568, Lactobacillus paracasei subsp. paracasei NTU 101, and the related products in order to achieve a comprehensive and “customized” service for product development.